CARSON LISA CABOTT (Chief Financial Officer) received a stock award from PHIO PHARMACEUTICALS CORP.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/29/2026ACC: 0001683168-26-007481
Officer· Chief Financial Officer
Since Feb 2026
+108K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
108K acquired
Non-Derivative Transactions1
Common Stock, $.0001 par value
Direct
Shares
+108K
Price / share
—
Trade value
—
% of position
133.1%
9/28/2026
81.11K→189.11K
Total
Net shares
+108K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.0001 par value Direct | 9/28/2026 | A · Award | +108K | — | — | 133.1% | 81.11K | 189.11K |
| Total | +108K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported